Sarah Barnard, PA
Physician Assistant · New Tazewell, TNNPI 1700160447
Payments from drug & device makers
Across 131 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$614
- AbbVie$293
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$230
- GSK$212
- Pfizer$144
- AstraZeneca$102
- plus $622 from 19 others
What the payments were for
- Food & beverage$2,216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $614 |
| AbbVie | 16 | $293 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $230 |
| GSK | 14 | $212 |
| Pfizer | 9 | $144 |
| AstraZeneca | 7 | $102 |
| Boehringer Ingelheim | 6 | $98 |
| Bayer | 4 | $78 |
| Johnson & Johnson | 3 | $50 |
| Amarin Pharma, Inc. | 3 | $49 |
| Corium, LLC | 3 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $28 |
| Lundbeck LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Abbott | 1 | $18 |
| Alkermes, Inc. | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Radius Health, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
How this compares
$2,216 in reported general payments places this provider in the 80th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 115 | $111,949 |
| TrulicityDulaglutide | 89 | $110,514 |
| MounjaroTirzepatide | 55 | $70,038 |
| JardianceEmpagliflozin | 62 | $60,048 |
| OzempicSemaglutide | 44 | $49,906 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $31,022 |
| FarxigaDapagliflozin Propanediol | 37 | $30,315 |
| JanuviaSitagliptin Phosphate | 34 | $25,599 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $21,398 |
| XareltoRivaroxaban | 13 | $12,510 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $11,240 |
| Lagevrio (Eua)Molnupiravir | 11 | $8,786 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $6,223 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 156 | $4,031 |
| Esomeprazole Magnesium | 95 | $3,146 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $28 | $180,552144 claims |
| PfizerEliquis, Paxlovid | $144 | $114,807133 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $102 | $62,95475 claims |
| Boehringer IngelheimJardiance | $98 | $60,04862 claims |
| Novo NordiskOzempic | $614 | $49,90644 claims |
| GSKTrelegy Ellipta | $212 | $31,02218 claims |
| Johnson & JohnsonXarelto | $50 | $12,51013 claims |
| AbbVieSynthroid | $293 | $2,06122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in New Tazewell
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
- Elisabeth BennettNashville$109K
- Whitney GatewoodMemphis$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.